Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

MYSM1 binds RBM10. 2 / 2

1 | 1

➶

biogrid

No evidence text available

17707232

➶

sparser

"Our transcriptomic analyses, which show no effect of RBM10 downregulation on alternative splicing in GLC20 cells, are supported by (1) our RBM10-only targets ( xref ), which are involved in various aspects of gene expression regulation, excluding alternative splicing, (2) RBM10’s mRNA stabilization effect on its only identified direct RNA target, the AT1 receptor [ xref ], and (3) RBM10’s interaction with the 2A-DUB deubiquitinase protein complex [ xref ] and the Rac-specific GTPase-activitating protein FilGAP [ xref ]."

28662214

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...